Gudrun Schleiermacher Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• Genomic profiling in low and intermediate risk neuroblastoma to refine treatment stratification and improve patient outcome – LINES: a SIOPEN Trial — Poster Session 2 with wine & cheese
• Genomic profiling using circulating free tumor DNA highlights heterogeneity in neuroblastoma — Poster Session 2 with wine & cheese
• OMS/DES 2011 : a Multinational European Trial for Children with Opsoclonus Myoclonus Syndrome — Poster Session 2 with wine & cheese
• Post surgical 123I-MIBG SPECT/CT in neuroblastoma — Poster Session 2 with wine & cheese
• High-risk neuroblastoma without MYCN amplification in patients between 12 and 18 months: Is there a hidden low-risk patient group? — Poster Session 2 with wine & cheese
• Overview of treatment for low- and intermediate-risk patients — Neuroblastoma Update - 1
• Panel Discussion — Workshop 3 - Emerging technologies for exploration of tumor heterogeneity, clonal evolution and progression in neuroblastoma